| |
| |
|
| Insider
Information: |
Keller William R |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
7,276 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,327,870 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
7,276 |
|
|
| Total
Value |
$1,327,870 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2014-12-04 |
7,276 |
2010-01-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-12-04 |
4 |
S |
$196.25 |
$981,250 |
D/D |
(5,000) |
7,276 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-06-05 |
4 |
S |
$170.00 |
$582,250 |
D/D |
(3,425) |
12,276 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-06-05 |
4 |
OE |
$96.35 |
$329,999 |
D/D |
3,425 |
15,701 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
13,171 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-05-20 |
4 |
S |
$103.00 |
$1,006,310 |
D/D |
(9,770) |
12,276 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-05-20 |
4 |
OE |
$23.05 |
$501,653 |
D/D |
9,770 |
22,046 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
12,276 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-02-23 |
4 |
S |
$84.78 |
$721,902 |
D/D |
(8,515) |
9,805 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-02-23 |
4 |
OE |
$23.05 |
$276,888 |
D/D |
8,515 |
18,320 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-03-02 |
4 |
S |
$97.00 |
$470,256 |
D/D |
(4,848) |
6,690 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-03-02 |
4 |
OE |
$46.10 |
$244,846 |
D/D |
4,848 |
11,538 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,725 |
6,690 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,965 |
3,965 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
